These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 24315373)
21. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. Ke XX; Zhang D; Zhu S; Xia Q; Xiang Z; Cui H PLoS One; 2014; 9(9):e106962. PubMed ID: 25198515 [TBL] [Abstract][Full Text] [Related]
22. The zinc finger proteins ZNF644 and WIZ regulate the G9a/GLP complex for gene repression. Bian C; Chen Q; Yu X Elife; 2015 Mar; 4():. PubMed ID: 25789554 [TBL] [Abstract][Full Text] [Related]
23. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer. Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140 [TBL] [Abstract][Full Text] [Related]
24. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651 [TBL] [Abstract][Full Text] [Related]
25. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes. Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012 [TBL] [Abstract][Full Text] [Related]
26. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB. Park SE; Yi HJ; Suh N; Park YY; Koh JY; Jeong SY; Cho DH; Kim CS; Hwang JJ Oncotarget; 2016 Jun; 7(26):39796-39808. PubMed ID: 27174920 [TBL] [Abstract][Full Text] [Related]
28. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408 [TBL] [Abstract][Full Text] [Related]
29. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390 [TBL] [Abstract][Full Text] [Related]
31. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma. Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509 [TBL] [Abstract][Full Text] [Related]
32. Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening. Charles MRC; Mahesh A; Lin SY; Hsieh HP; Dhayalan A; Coumar MS Biochimie; 2020 Jan; 168():220-230. PubMed ID: 31756401 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation. Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331 [TBL] [Abstract][Full Text] [Related]
34. G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma. Li F; Zeng J; Gao Y; Guan Z; Ma Z; Shi Q; Du C; Jia J; Xu S; Wang X; Chang L; He D; Guo P PLoS One; 2015; 10(9):e0138390. PubMed ID: 26397365 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway. Ho JC; Abdullah LN; Pang QY; Jha S; Chow EK; Yang H; Kato H; Poellinger L; Ueda J; Lee KL PLoS One; 2017; 12(11):e0188051. PubMed ID: 29145444 [TBL] [Abstract][Full Text] [Related]
36. Ethanol induced acetylation of histone at G9a exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice. Subbanna S; Nagre NN; Shivakumar M; Umapathy NS; Psychoyos D; Basavarajappa BS Neuroscience; 2014 Jan; 258():422-32. PubMed ID: 24300108 [TBL] [Abstract][Full Text] [Related]
37. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma. Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420 [TBL] [Abstract][Full Text] [Related]
38. Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. Papait R; Serio S; Pagiatakis C; Rusconi F; Carullo P; Mazzola M; Salvarani N; Miragoli M; Condorelli G Circulation; 2017 Sep; 136(13):1233-1246. PubMed ID: 28778944 [TBL] [Abstract][Full Text] [Related]
39. Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis. Pande P; Zhong XB; Ku WW Drug Metab Dispos; 2020 Dec; 48(12):1321-1329. PubMed ID: 33077425 [TBL] [Abstract][Full Text] [Related]
40. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Chae YC; Kim JY; Park JW; Kim KB; Oh H; Lee KH; Seo SB Nucleic Acids Res; 2019 Feb; 47(4):1692-1705. PubMed ID: 30535125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]